The third quarter saw many novel drugs receiving FDA-approval for a variety of conditions often seen in primary care.
Rates of adherence to cystic fibrosis treatment plans have been reported as low as 36%. The motivational interviewing approach could help, according to MI trainer Ellen R. Glovsky, PhD, RD, LDN.
Motivational interviewing uses the common human problem of ambivalence about change to help clients shape their own solutions.
The European and American guidelines on dyslipidemia management overlap but also diverge in critical ways. A Johns Hopkins cardiologist highlights similarities and differences.
A new study suggests that deep brain stimulation may be a safe and effective treatment option for patients with treatment-resistant depression.
Children, tweens, and adolescents with migraine can use Migraine Trainer to log and share details that will help physicians individualize care in this vulnerable population.
For people with type 2 diabetes, receiving motivational messages via mobile text was associated with reduced A1c vs patients who received usual care.
The FDA announced October 3 approval of Descovy®, making it the second drug to receive indication for HIV pre-exposure prophylaxis.
Throbbing occipital headache x2 wks; abrupt onset, no history. Reason for alarm? Neurologist Peter McAllister, MD, suggests you SNOOP first.
Vaccines against herpes and chlamydia show promise but sexual health awareness in the US leaves a lot to be desired. The research explains.